Vivos Therapeutics shares are trading higher after the company announced it executed strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers.
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics has entered into strategic agreements with Ormco and On Demand Orthodontist to supply Spark Clear Aligners to its national network of providers. This has led to an increase in Vivos' share price.
October 04, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vivos Therapeutics' stock is trading higher following the announcement of strategic agreements with Ormco and On Demand Orthodontist.
The strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers is a positive development for Vivos Therapeutics. This could potentially increase the company's revenues and profitability, which is likely why the stock price has increased.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100